KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Shares Outstanding (Diluted Average): 2018-2024

Historic Shares Outstanding (Diluted Average) for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $29.3 million.

  • Castle Biosciences' Shares Outstanding (Diluted Average) fell 1.12% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year decrease of 1.12%. This contributed to the annual value of $29.3 million for FY2024, which is 9.15% up from last year.
  • According to the latest figures from FY2024, Castle Biosciences' Shares Outstanding (Diluted Average) is $29.3 million, which was up 9.15% from $26.8 million recorded in FY2023.
  • Castle Biosciences' Shares Outstanding (Diluted Average)'s 5-year high stood at $29.3 million during FY2024, with a 5-year trough of $18.9 million in FY2020.
  • In the last 3 years, Castle Biosciences' Shares Outstanding (Diluted Average) had a median value of $26.8 million in 2023 and averaged $27.4 million.
  • Data for Castle Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY soared of 118.63% (in 2020) over the last 5 years.
  • Castle Biosciences' Shares Outstanding (Diluted Average) (Yearly) stood at $18.9 million in 2020, then skyrocketed by 32.80% to $25.1 million in 2021, then rose by 3.65% to $26.1 million in 2022, then grew by 2.87% to $26.8 million in 2023, then grew by 9.15% to $29.3 million in 2024.